Tuberculosis Trial, Recruiting NCT07164742 Sponsor: Johns Hopkins University Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT07164742
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been confirmed to have TB in your lungs through a lab test (such as a sputum smear, GeneXpert test, or culture)
  • You have not been on TB treatment for more than 2 weeks at the time of joining
  • You are receiving your TB care at one of the outpatient clinics involved in the TB PuRe study
  • You are willing and able to attend study check-ups and evaluations for 48 weeks (about 1 year)
  • You have access to a smartphone

Who may not be able to join:

  • You have no shortness of breath during everyday activities — meaning breathlessness only happens during very hard physical effort (confirm with trial site)
  • You have a form of TB that is resistant to multiple or many drugs (sometimes called MDR-TB or XDR-TB)
  • You have TB that only affects parts of the body other than the lungs, with no lung involvement
  • You have TB affecting the brain (TB meningitis) or the spine
  • You have a known heart condition, such as blocked heart arteries, an irregular heartbeat, or heart failure
  • Your overall health and ability to carry out daily activities is very poor, as measured by a specific health scoring tool (confirm with trial site)
  • You have any medical condition that would prevent you from doing physical rehabilitation exercises, such as a broken arm or leg, or if you are pregnant
  • You are currently using any inhaled or other breathing medications, such as inhalers for asthma or steroids

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Akshay Gupte, PhD MBBS MSPH, Boston University

Phone: 617-358-2454

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 March 2026
Est. completion
15 September 2028

Where this trial is recruiting

🇮🇳 India

Primary endpoints

Six-Minute Walk Test (6MWT) distance (meters)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov